CN Patent

CN105764487A — Amg 416（velcalcetide）的稳定的液体制剂

Assigned to Amgen Inc · Expires 2016-07-13 · 10y expired

What this patent protects

本发明提供一种包含钙敏感受体的肽激动剂的液体制剂和制备和使用该制剂的方法。

USPTO Abstract

本发明提供一种包含钙敏感受体的肽激动剂的液体制剂和制备和使用该制剂的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105764487A
Jurisdiction
CN
Classification
—
Expires
2016-07-13
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.